Dietary choline and betaine intakes and risk of cardiovascular diseases: Review of epidemiological evidence

ARYA Atherosclerosis

Volumn 7, Issue 2, 2011, Pages 78-86

  Rajaie, Somayeh ^a   Esmaillzadeh, Ahmad ^b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Betaine; Cardiovascular diseases; Choline; Inflammation; Metabolic syndrome

Indexed keywords

EID: 84858118626     PISSN: 17353955     EISSN: 22516638     Source Type: Journal    
DOI: None     Document Type: Review

References (74)

1. Sarraf-Zadegan N, Sayed-Tabatabaei FA, Bashardoost N, Maleki A, Totonchi M, Habibi HR, et al. The prevalence of coronary artery disease in an urban population in Isfahan, Iran. Acta Cardiol 1999; 54(5): 257-63.
2. Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K, et al. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation 2003; 108(19): 2317-22.
3. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340(2): 115-26.
4. Konstantinova SV, Tell GS, Vollset SE, Nygard O, Bleie O, Ueland PM. Divergent associations of plasma choline and betaine with components of metabolic syndrome in middle age and elderly men and women. J Nutr 2008; 138(5): 914-20.
5. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995; 274(13): 1049-57.
6. Eikelboom JW, Lonn E, Genest J, Hankey G, Yusuf S. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 1999; 131(5): 363-75.
7. Ueland PM, Refsum H, Beresford SA, Vollset SE. The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr 2000; 72(2): 324-32.
8. Graham IM, Daly LE, Refsum HM. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997; 277(22): 1775-81.
9. Brattstrom L, Wilcken DE. Homocysteine and cardiovascular disease: cause or effect? Am J Clin Nutr 2000; 72(2): 315-23.
10. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 2002; 288(16): 2015-22.
11. Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullmann D, et al. A Prospective Study of Plasma Homocyst(e)ine and Risk of Myocardial Infarction in US Physicians. JAMA 1992; 268(7): 877-81.
12. Ridker PM, Manson JE, Buring JE, Shih J, Matias M, Hennekens CH. Homocysteine and risk of cardiovascular disease among postmenopausal women. JAMA 1999; 281(19): 1817-21.
13. Schnyder G, Roffi M, Pin R, Flammer Y, Lange H, Eberli FR, et al. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med 2001; 345(22): 1593-600.
14. Shai I, Stampfer MJ, Ma J, Manson JE, Hankinson SE, Cannuscio C, et al. Homocysteine as a risk factor for coronary heart diseases and its association with inflammatory biomarkers, lipids and dietary factors. Atherosclerosis 2004; 177(2): 375-81.
15. Papatheodorou L, Weiss N. Vascular oxidant stress and inflammation in hyperhomocysteinemia. Antioxid Redox Signal 2007; 9(11): 1941-58.
16. Meigs JB, Jacques PF, Selhub J, Singer DE, Nathan DM, Rifai N, et al. Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study. Diabetes Care 2001; 24(8): 1403-10.
17. Steenge GR, Verhoef P, Katan MB. Betaine supplementation lowers plasma homocysteine in healthy men and women. J Nutr 2003; 133(5): 1291-5.
18. Hajer GR, van der GY, Olijhoek JK, Verhaar MC, Visseren FL. Levels of homocysteine are increased in metabolic syndrome patients but are not associated with an increased cardiovascular risk, in contrast to patients without the metabolic syndrome. Heart 2007; 93(2): 216-20.
19. Zeisel SH, Da Costa KA, Franklin PD, Alexander EA, Lamont JT, Sheard NF, et al. Choline, an essential nutrient for humans. FASEB J 1991; 5(7): 2093-8.
20. Zeisel SH, Niculescu MD. Choline and Phosphatidylcholine. In: Shils ME, Shike M, Editors. Modern nutrition in health and disease. 10th ed. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 252-36.
21. Yates AA, Schlicker SA, Suitor CW. Dietary Reference Intakes: the new basis for recommendations for calcium and related nutrients, B vitamins, and choline. J Am Diet Assoc 1998; 98(6):699-706.
22. Resseguie M, Song J, Niculescu MD, Da Costa KA, Randall TA, Zeisel SH. Phosphatidylethanolamine Nmethyltransferase (PEMT) gene expression is induced by estrogen in human and mouse primary hepatocytes. FASEB J 2007; 21(10): 2622-32.
23. Fischer L, DaCosta K, Kwock L, Zeisel S. Sex and menopausal status influence human dietary requirements for the nutrient choline. Am J Clin Nutr 2007; 85(5): 1275-85.
24. Howe JC, Williams JR. USDA database for the choline content of common foods-2004 [Online]. 2004 May 4 [cited 2007 Nov 8]; Available from: URL: http://www.nal.usda.gov/fnic/foodcomp/data/choline/choline.html/
25. Zeisel SH, Mar MH, Howe JC, Holden JM. Concentrations of choline-containing compounds and betaine in common foods. J Nutr 2003; 133(5): 1302-7.
26. Zeisel SH, Blusztajn JK. Choline and human nutrition. Annu Rev Nutr 1994; 14: 269-96.
27. Little A, Levy R, Chuaqui-Kidd P, Hand D. A double-blind, placebo controlled trial of high-dose lecithin in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1985; 48(8): 736-42.
28. Da Costa KA, Gaffney CE, Fischer LM, Zeisel SH. Choline deficiency in mice and humans is associated with increased plasma homocysteine concentration after a methionine load. Am J Clin Nutr 2005; 81(2): 440-4.
29. Institute of Medicine, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. Washington (DC): National Academies Press; 1998.
30. Niculescu MD, Craciunescu CN, Zeisel SH. Dietary choline deficiency alters global and gene-specific DNA methylation in the developing hippocampus of mouse fetal brains. FASEB J 2006; 20(1): 43-9.
31. Craig SA. Betaine in human nutrition. Am J Clin Nutr 2004; 80(3): 539-49.
32. Chern MK, Pietruszko R. Evidence for mitochondrial localization of betaine aldehyde dehydrogenase in rat liver: purification, characterization, and comparison with human cytoplasmic E3 isozyme. Biochem Cell Biol 1999; 77(3): 179-87.
33. Ueland PM, Holm PI, Hustad S. Betaine: a key modulator of one-carbon metabolism and homocysteine status. Clin Chem Lab Med 2005; 43(10): 1069-75.
34. Finkelstein JD, Harris BJ, Kyle WE. Methionine metabolism in mammals: kinetic study of betainehomocysteine methyltransferase. Arch Biochem Biophys 1972; 153(1): 320-4.
35. Melse-Boonstra A, Holm PI, Ueland PM, Olthof M, Clarke R, Verhoef P. Betaine concentration as a determinant of fasting total homocysteine concentrations and the effect of folic acid upplementation on betaine concentrations. Am J Clin Nutr 2005; 81(6): 1378-82.
36. Garrow TA. Betaine-dependent remethylation. In: Carmel R, Jacobsen DW, Editors. Homocysteine in health and disease. Cambridge: Cambridge University Press; 2001. p. 145-52.
37. Ward M, McNulty H, McPartlin J, Strain JJ, Weir DG, Scott JM. Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological doses of folic acid. QJM 1997; 90(8): 519-24.
38. Brouwer IA, van Dusseldorp M, Thomas CM, Duran M, Hautvast JG, Eskes TK, et al. Low-dose folic acid supplementation decreases plasma homocysteine concentrations: a randomized trial. Am J Clin Nutr 1999; 69(1): 99-104.
39. Mansoor MA, Kristensen O, Hervig T, Bates CJ, Pentieva K, Vefring H, et al. Plasma total homocysteine response to oral doses of folic acid and pyridoxine hydrochloride (vitamin B6) in healthy individuals. Oral doses of vitamin B6 reduce concentrations of serum folate. Scand J Clin Lab Invest 1999; 59(2): 139-46.
40. Van Guldener C, Janssen MJ, de Meer K, Donker AJ, Stehouwer CD. Effect of folic acid and betaine on fasting and postmethionine-loading plasma homocysteine and methionine levels in chronic haemodialysis patients. J Intern Med 1999; 245(2): 175-83.
41. Fernandez-Miranda C, Gomez P, Diaz-Rubio P, Estenoz J, Carillo JL, Andres A, et al. Plasma homocysteine levels in renal transplanted patients on cyclosporine or tacrolimus therapy: effect of treatment with folic acid. Clin Transplant 2000; 14(2): 110-4.
42. Bostom AG, Gohh RY, Beaulieu AJ, Nadeau MR, Hume AL, Jacques PF, et al. Treatment of hyperhomocysteinemia in renal transplant recipients. A randomized, placebo-controlled trial. Ann Intern Med 1997; 127(12): 1089-92.
43. Nelen WL, Blom HJ, Thomas CM, Steegers EA, Boers GH, Eskes TK. Methylenetetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexplained recurrent miscarriages. J Nutr 1998; 128(8): 1336-41.
44. Chao CL, Chien KL, Lee YT. Effect of short-term vitamin (folic acid, vitamins B6 and B12) administration on endothelial dysfunction induced by post-methionine load hyperhomocysteinemia. Am J Cardiol 1999; 84(11): 1359-61, A8.
45. Brouwer IA, Verhoef P, Urgert R. Betaine supplementation and plasma homocysteine in healthy volunteers. Arch Intern Med 2000; 160(16): 2546-7.
46. Schwab U, Torronen A, Toppinen L, Alfthan G, Saarinen M, Aro A, et al. Betaine supplementation decreases plasma homocysteine concentrations but does not affect body weight, body composition, or resting energy expenditure in human subjects. Am J Clin Nutr 2002; 76(5): 961-7.
47. Olthof MR, Brink EJ, Katan MB, Verhoef P. Choline supplemented as phosphatidylcholine decreases fasting and postmethionine-loading plasma homocysteine concentrations in healthy men. Am J Clin Nutr 2005; 82(1): 111-7.
48. Cho E, Zeisel SH, Jacques P, Selhub J, Dougherty L, Colditz GA, et al. Dietary choline and betaine assessed by food-frequency questionnaire in relation to plasma total homocysteine concentration in the Framingham Offspring Study. Am J Clin Nutr 2006; 83(4): 905-11.
49. Dalmeijer GW, Olthof MR, Verhoef P, Bots ML, Van der Schouw YT. Prospective study on dietary intakes of folate, betaine, and choline and cardiovascular disease risk in women. Eur J Clin Nutr 2008; 62(3): 386-94.
50. Chiuve SE, Giovannucci EL, Hankinson SE, Zeisel SH, Dougherty LW, Willett WC, et al. The association between betaine and choline intakes and the plasma concentrations of homocysteine in women. Am J Clin Nutr 2007; 86(4): 1073-81.
51. Sachan DS, Hongu N, Johnsen M. Decreasing oxidative stress with choline and carnitine in women. J Am Coll Nutr 2005; 24(3): 172-6.
52. Bidulescu A, Chambless LE, Siega-Riz AM, Zeisel SH, Heiss G. Usual choline and betaine dietary intake and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. BMC Cardiovasc Disord 2007; 7: 20.
53. Howe JC, Williams JR, Holden JM, Zeisel SH, Mar MH. USDA Database for the Choline Content of Common Foods [Online]. 2004; Available from: URL: http://www.nal.usda.gov/fnic/foodcomp/data/choline/choline.html/
54. Detopoulou P, Panagiotakos DB, Antonopoulou S, Pitsavos C, Stefanadis C. Dietary choline and betaine intakes in relation to concentrations of inflammatory markers in healthy adults: the ATTICA study. Am J Clin Nutr 2008; 87(2): 424-30.
55. Zeisel SH. Is there a new component of the Mediterranean diet that reduces inflammation? Am J Clin Nutr 2008; 87(2): 277-8.
56. Olthof MR, van Vliet T, Verhoef P, Zock PL, Katan MB. Effect of homocysteine-lowering nutrients on blood lipids: results from four randomised, placebocontrolled studies in healthy humans. PLoS Med 2005; 2(5): e135.
57. Finkelstein JD, Martin JJ, Harris BJ, Kyle WE. Regulation of hepatic betaine-homocysteine methyltransferase by dietary betaine. J Nutr 1983; 113(3): 519-21.
58. Park EI, Renduchintala MS, Garrow TA. Diet- Induced Changes in Hepatic Betaine-Homocysteine Methyltransferase Activity Are Mediated By Changes in the Steady-State Level of Its mRNA. Nutr Biochem 1997; 8(9): 541-5.
59. Loscalzo J. Homocysteine trials--clear outcomes for complex reasons. N Engl J Med 2006; 354(15): 1629-32.
60. Sparks JD, Collins HL, Chirieac DV, Cianci J, Jokinen J, Sowden MP, et al. Hepatic very-lowdensity lipoprotein and apolipoprotein B production are increased following in vivo induction of betainehomocysteine S-methyltransferase. Biochem J 2006; 395(2): 363-71.
61. Rivera CA, Wheeler MD, Enomoto N, Thurman RG. A choline-rich diet improves survival in a rat model of endotoxin shock. Am J Physiol 1998; 275(4 Pt 1): G862-G867.
62. Vrablic AS, Albright CD, Craciunescu CN, Salganik RI, Zeisel SH. Altered mitochondrial function and overgeneration of reactive oxygen species precede the induction of apoptosis by 1-O-octadecyl-2-methylrac- glycero-3-phosphocholine in p53-defective hepatocytes. FASEB J 2001; 15(10): 1739-44.
63. Banni S, Corongiu FP, Dessi MA, Iannone A, Lombardi B, Tomasi A, et al. Free radicals and lipid peroxidation in liver of rats kept on a diet devoid of choline. Free Radic Res Commun 1989; 7(3-6): 233-40.
64. Da Costa KA, Niculescu MD, Craciunescu CN, Fischer LM, Zeisel SH. Choline deficiency increases lymphocyte apoptosis and DNA damage in humans. Am J Clin Nutr 2006; 84(1): 88-94.
65. Kim SK, Kim SY, Kim YC. Effect of betaine administration on metabolism of hepatic glutathione in rats. Arch Pharm Res 1998; 21(6): 790-2.
66. Grimble RF. The effects of sulfur amino acid intake on immune function in humans. J Nutr 2006; 136(6 Suppl): 1660S-5S.
67. Majano PL, Garcia-Monzon C, Garcia-Trevijano ER, Corrales FJ, Camara J, Ortiz P, et al. SAdenosylmethionine modulates inducible nitric oxide synthase gene expression in rat liver and isolated hepatocytes. J Hepatol 2001; 35(6): 692-9.
68. Chawla RK, Watson WH, Eastin CE, Lee EY, Schmidt J, McClain CJ. S-adenosylmethionine deficiency and TNF-alpha in lipopolysaccharideinduced hepatic injury. Am J Physiol 1998; 275(1 Pt 1): G125-G129.
69. Song Z, Zhou Z, Chen T, Hill D, Kang J, Barve S, et al. S-adenosylmethionine (SAMe) protects against acute alcohol induced hepatotoxicity in mice small star, filled. J Nutr Biochem 2003; 14(10): 591-7.
70. Brosnan JT, Brosnan ME. The sulfur-containing amino acids: an overview. J Nutr 2006; 136(6 Suppl): 1636S-40S.
71. Zeisel SH. Choline: critical role during fetal development and dietary requirements in adults. Annu Rev Nutr 2006; 26: 229-50.
72. Nisoli E, Clementi E, Carruba MO, Moncada S. Defective mitochondrial biogenesis: a hallmark of the high cardiovascular risk in the metabolic syndrome? Circ Res 2007; 100(6): 795-806.
73. Lin CS, Wu RD. Choline oxidation and choline dehydrogenase. N Engl J Med 1986; 5(3): 193-200.
74. Medina M, Urdiales JL, Amores-Sanchez MI. Roles of homocysteine in cell metabolism: old and new functions. Eur J Biochem 2001; 268(14): 3871-82.